Cited 0 times in
Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.